Science & Tech

Data science provides a foundation for an important front in the battle against COVID-19. The Harvard Data Science Review, a journal of the Harvard Data Science Initiative, is helping keep data scientists connected and up to date on the latest findings.

Toe springs in shoes make walking easier but may come at a cost.

In his new book Joe Henrich looks at how the West became psychologically peculiar and prosperous.

Researchers have built two machine learning models that gauge biological age and predict remaining lifespan in mice.

Harvard and Chinese scientists study Cambrian fossils using micro-CT and 3D models.

Harvard researchers become the first to cool a polyatomic molecule using light.

A look at COVID-19 contact tracing efforts at Harvard.

A team of undergrads is using computational biology to create a therapeutic that enables the body to quickly develop COVID-19 antibodies and jump-start the immune system’s battle against the disease.

CfA astronomers theorize that the solar system originally had two suns as they further research a sneezing star and ‘Oumuamua.

SEAS researchers have developed a material made from recycled wool can be 3D-printed into any shape and pre-programmed with reversible shape memory.

According to new study, bonobo hunting tendencies show proof of culture

Researchers led by Christian Rutz, 2019–2020 Grass Fellow at the Radcliffe Institute for Advanced Study, are examining human impact on wildlife using data collected during the pandemic quarantine.

Researchers have developed a synthetic lining that could deliver drugs in a sustained way to the small intestine, offering hope for those suffering from lactose intolerance, diabetes, and obesity.

In a collaboration between Harvard and Sony, engineers have brought surgical robotics down to the microscale by creating a new, origami-inspired miniature manipulator to improve precision and control.

The seductive powers, dark history, health benefits, and harmful side effects of the world’s most-used drug, are included in Michael Pollan’s new audiobook, “Caffeine: How Coffee and Tea Created the Modern World.”

A biomaterials-based infection vaccine strategy shows first promise in eliciting immunity against SARS-CoV-2 and could be applied broadly to stave off infectious disease.

The Wyss Institute made improvements to its face shields based on recommendations from area hospitals. Joining forces with a Mansfield, Mass.-based manufacturer, the institute’s face shields are now being produced at a rate of 400,000 a day.

Acupuncture activates inflammation-regulating pathways, tames cytokine storm in mice.

Harvard neuroscientists look at how movement influences vision and perception.

Harvard University researchers have identified a unique characteristic of the resistant cancer cells, which could lead to an inhibitor can be repurposed and combined with chemotherapy to improve patient outcomes.

Emily Balskus has won the Alan T. Waterman Award, the National Science Foundation’s most prestigious prize for scientists under 40 in the United States.

Researchers at the Arnold Arboretum are studying how maple trees are adapting to climate change.

The rate at which carbon is captured from the atmosphere at Harvard Forest nearly doubled between 1992 and 2015, a 25-year study reveals.

A new species of bacteria, one that makes its home on the relatively hot and dry surface of a solar panel, was discovered recently at the Arnold Arboretum, offering a lesson that nature’s reach extends even to the artificial.

New quantum-classical algorithm brings nuclear magnetic resonance readings closer to “near-term” quantum computing.

Project aims to give young students real-life STEM role models

With the goal of reducing food waste, a student-developed device predicts when an avocado will be ripe

When scientists moved from manipulating atoms to messing with molecules, molecules started to disappear from view. Professor Kang-Kuen Ni has figured out why.

Researchers have created a treatment that when applied directly to the skin in a mouse model of psoriasis, significantly reduces levels of inflammation and symptoms of psoriasis without systemic side effects.

The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.